• 1
    Cines DB,Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 9951008.
  • 2
    Cines DB,Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005; 106: 22442251.
  • 3
    George JN,El-Harake MA,Aster RH. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: BeutlerE,LichtmanMA,CollerBS,KippsTJ, editors. Williams Hematology, 5th ed. New York: McGraw-Hill. 1995. pp 13151355.
  • 4
    McMillan R,Imbach P. Immune thrombocytopenic purpura. In: LoscalzoJ,SchaferA, editors. Thrombosis and Hemorrhage. Philadelphia: Lippincott Williams & Wilkins; 2003. pp 476495.
  • 5
    George JN,Woolf SH,Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 340.
  • 6
    Provan D,Newland A,Bolton-Maggs P. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574596.
  • 7
    Cohen YC,Djulbegovic B,Shamai-Lubovitz O,Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 2000; 160: 16301638.
  • 8
    McMillan R,Durette C. The long-term outcome of adult chronic ITP patients who fail splenectomy. Blood 2004; 104: 956960.
  • 9
    Barnard D,Woloski M,Feeney D, et al. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol 2003; 25: 5662.
  • 10
    Streiner DL,Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford: Oxford University Press; 1995.
  • 11
    Ware J. SF-36 Health Survey, manual and interpretation guide. Boston: New England Medical Center, The Health Institute; 1993.
  • 12
    Shrout PE,Fleiss JL. Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 1979; 2: 420428.
  • 13
    Cines DB,McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 2005; 56: 425442.
  • 14
    Kojouri K,Vesely SK,Terrell DR,George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004; 104: 26232634.
  • 15
    Stewart AL,Ware JE. Measuring functioning and well-being: The medical outcomes study approach. Methods of validating health measures. Durham, NC: Duke University Press; 1992.
  • 16
    Ware J. SF-36 Physical and Mental Health Summary Scales: A Manual and Interpretation Guide. Boston: The Health Institute; 1994.
  • 17
    Ware JE,Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I: Conceptual framework and item selection. Med Care 1992; 30: 473483.
  • 18
    Ware JE,Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 945952.
  • 19
    Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297334.